LADENBURG THALMANN FINANCIAL SERVICES INC. - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$1,0000.0%840.0%0.00%
Q4 2015$1,000
-66.7%
84
-78.2%
0.00%
Q3 2015$3,000
-25.0%
385
-11.1%
0.00%
Q2 2015$4,000433
+1961.9%
0.00%
Q1 2015$0210.0%0.00%
Q4 2014$021
-19.2%
0.00%
Q3 2013$0260.0%0.00%
Q2 2013$0260.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Athos Capital Ltd 284,200$3,126,0001.80%
Nine Chapters Capital Management LLC 13,600$150,0001.42%
Stonepine Capital Management, LLC 216,307$2,379,0001.28%
GLG Partners LP 1,588,897$17,478,0000.97%
MENTA CAPITAL LLC 431,996$4,752,0000.56%
Sapphire Star Partners LP 24,834$273,0000.34%
Yakira Capital Management, Inc. 85,500$941,0000.28%
TFS CAPITAL LLC 55,104$606,0000.24%
BRANT POINT INVESTMENT MANAGEMENT LLC 100,000$1,100,0000.13%
GABELLI & Co INVESTMENT ADVISERS, INC. 102,261$1,125,0000.12%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders